| Literature DB >> 31491977 |
Mo Zhang1, Li Li2, Ying Liu3,4, Xiaolong Gao5.
Abstract
In this experiment, the effects of a sudden drop of salinity on the immune response mechanisms of the ark shell Anadara kagoshimensis were examined by simulating the sudden drop of salinity that occurs in seawater after a rainstorm. Additionally, the differentially expressed genes (DEGs) were identified using transcriptome sequencing. When the salinity dropped from 30‱ (S30) to 14‱ (S14), the phagocytic activity of blood lymphocytes, the O2- levels produced from respiratory burst, the content of reactive oxygen species, and the activities of lysozymes and acid phosphatases increased significantly, whereas the total count of blood lymphocytes did not increase. Total count of blood lymphocytes in 22‱ salinity (S22) was significantly higher than that in any other group. The raw data obtained from sequencing were processed with Trimmomatic (Version 0.36). The expression levels of unigenes were calculated using transcripts per million (TPM) based on the effects of sequencing depth, gene length, and sample on reads. Differential expression analysis was performed using DESeq (Version 1.12.4). Transcriptome sequencing revealed 269 (101 up-regulated, 168 down-regulated), 326 (246 up-regulated, 80 down-regulated), and 185 (132 up-regulated, 53 down-regulated) significant DEGs from comparison of the S14 vs. S22, S22 vs. S30, and S14 vs. S30 groups, respectively. Gene Ontology enrichment analysis of the DEGs in these salinity comparison groups revealed that the cellular amino acid metabolic process, the regulation of protein processing, the regulation of response to stress, and other terms were significantly enriched. Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that nucleotide-binding, oligomerization domain (NOD)-like receptor signaling pathway (ko04621), apoptosis-multiple species (ko04215), Toll and Imd signaling pathway (ko04624), NF-κB signaling pathway (ko04064), apoptosis (ko04210), and focal adhesion (ko04510) were significantly enriched in all salinity comparison groups. qRT-PCR verification of 12 DEGs in the above six pathways was conducted, and the results were consistent with the transcriptome sequencing results in terms of up-regulation and down-regulation, which illustrates that the transcriptome sequencing data are credible. These results were used to preliminarily explore the effects of a sudden drop of salinity on blood physiological and biochemical indexes and immunoregulatory mechanisms of A. kagoshimensis. They also provide a theoretical basis for the selection of bottom areas optimal for release and proliferation of A. kagoshimensis required to restore the declining populations of this species.Entities:
Keywords: Anadara kagoshimensis; cellular immunity; real-time quantitative PCR; salinity; transcriptomics
Mesh:
Substances:
Year: 2019 PMID: 31491977 PMCID: PMC6769905 DOI: 10.3390/ijms20184365
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Effects of a sudden drop in salinity on total hemocyte counts, phagocytic activity, respiratory burst activity, and reactive oxygen species (ROS) content of Anadara kagoshimensis.
| Index | Salinity Treatments | ANOVA | ||
|---|---|---|---|---|
| 30‰ | 22‰ | 14‰ | ||
| Total hemocyte counts (×107 cells·mL−1) | 2.43 ± 0.19 b | 2.97 ± 0.31 a | 2.15 ± 0.24 b | 0.002 |
| Phagocytic activity (%) | 15.26 ± 2.26 c | 22.46 ± 4.17 b | 30.95 ± 3.55 a | <0.001 |
| Respiratory burst activity (OD630/107 cells·mL−1) | 0.36 ± 0.03 b | 0.41 ± 0.07 b | 0.53 ± 0.04 a | 0.001 |
| Reactive Oxygen Species (A.U.) | 48.21 ± 8.77 b | 106.38 ± 15.61 b | 462.19 ± 39.24 a | <0.001 |
Values represent means and standard errors of three replicates (means ± SE; n = 9). Values in the same row that had different superscripts are significantly different at p < 0.05 based on Tukey’s test.
Figure 1Effects of a sudden drop in salinity on the activities of lysozyme (LZM) and acid phosphatase (ACP) in Anadara kagoshimensis. Values are expressed as mean ± SE (n = 9). Statistical analysis was performed by one-way ANOVA followed by Tukey’s test using SPSS version 18.0. Means with different lower case letters are significantly different at p < 0.05 level.
Summary of transcriptome sequencing and assembly for Anadara kagoshimensis.
| Items | All Number | >=500 bp Number | >=1000 bp Number | N50 Length of Unigenes (bp) | N90 Length of Unigenes (bp) | Max Length (bp) | Min Length (bp) | Total Length (bp) | Average Length (bp) |
|---|---|---|---|---|---|---|---|---|---|
| Transcript | 480,426 | 206,812 | 94,603 | 1070 | 293 | 16,628 | 201 | 344,014,385 | 716.06 |
| Unigene | 194,861 | 71,917 | 30,728 | 933 | 265 | 16,628 | 201 | 125,490,202 | 644 |
Statistics of functional annotation.
| Database | Number of Genes | Percentage (%) |
|---|---|---|
| Annotated in CDD | 22,654 | 11.63 |
| Annotated in KOG | 19,868 | 10.2 |
| Annotated in NR | 36,240 | 18.6 |
| Annotated in NT | 15,928 | 8.17 |
| Annotated in PFAM | 16,875 | 8.66 |
| Annotated in Swissprot | 30,091 | 15.44 |
| Annotated in TrEMBL | 35,539 | 18.24 |
| Annotated in GO | 33,522 | 17.2 |
| Annotated in KEGG | 12,644 | 6.49 |
| Annotated in at least one database | 45,883 | 23.55 |
| Annotated in all database | 3000 | 1.54 |
| Total genes | 194,861 | 100 |
CDD: conserved domain database; KOG: eukaryotic orthologous groups; NR: NCBI non-redundant protein; NT: NCBI non-redundant nucleotide sequences; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes.
Number of differentially expressed genes of Anadara kagoshimensis among different salinity treatments.
| Comparison | Number of Differentially Expressed Genes | ||
|---|---|---|---|
| Up-Regulated | Down-Regulated | Total Number | |
| S14 vs. S22 | 101 | 168 | 269 |
| S22 vs. S30 | 246 | 80 | 326 |
| S14 vs. S30 | 132 | 53 | 185 |
Figure 2Number of differentially expressed genes (DEGs) of Anadara kagoshimensis among different salinity treatments. The x-axis represents the pairwise comparisons, and the y-axis shows the number of DEGs screened. Orange bars denote up-regulated genes, and blue bars indicate down-regulated genes.
Figure 3Hierarchical clustering of DEGs in the three groups of Anadara kagoshimensis with different salinity treatments. The intensity of the color from green to red indicates the magnitude of differential expression. Orange and blue indicate up- and down-regulation, respectively.
Significantly enriched GO terms in DEGs at different salinity treatments.
| Go No. | Go Term | Significant (n/m) | Annotated (N/M) | Corrected | |
|---|---|---|---|---|---|
|
| |||||
| GO:1901605 | alpha-amino acid metabolic process | 9/54 | 499/26,336 | 0.00000073 | 0.006428865 |
| GO:0006541 | glutamine metabolic process | 5/54 | 85/26,336 | 0.00000087 | 0.006428865 |
| GO:0006520 | cellular amino acid metabolic process | 10/54 | 728/26,336 | 0.000002 | 0.00960635 |
| GO:1901607 | alpha-amino acid biosynthetic process | 6/54 | 191/26,336 | 0.0000026 | 0.00960635 |
| GO:0006542 | glutamine biosynthetic process | 3/54 | 15/26,336 | 0.0000036 | 0.01064088 |
| GO:0008652 | cellular amino acid biosynthetic process | 6/54 | 219/26,336 | 0.0000057 | 0.01404005 |
| GO:0043436 | oxoacid metabolic process | 15/54 | 1991/26,336 | 0.0000073 | 0.015412386 |
| GO:0006082 | organic acid metabolic process | 15/54 | 2015/26,336 | 0.0000085 | 0.015702688 |
| GO:0035499 | carnosine biosynthetic process | 2/54 | 3/26,336 | 0.000012 | 0.019705333 |
| GO:0019752 | carboxylic acid metabolic process | 14/54 | 1881/26,336 | 0.000018 | 0.0266022 |
| GO:0016053 | organic acid biosynthetic process | 8/54 | 586/26,336 | 0.000024 | 0.028421154 |
| GO:0046394 | carboxylic acid biosynthetic process | 8/54 | 586/26,336 | 0.000024 | 0.028421154 |
| GO:0009064 | glutamine family amino acid metabolic process | 5/54 | 169/26,336 | 0.000025 | 0.028421154 |
| GO:0006548 | histidine catabolic process | 2/54 | 5/26,336 | 0.000041 | 0.033663278 |
| GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate | 2/54 | 5/26,336 | 0.000041 | 0.033663278 |
| GO:0035498 | carnosine metabolic process | 2/54 | 5/26,336 | 0.000041 | 0.033663278 |
| GO:0050812 | regulation of acyl-CoA biosynthetic process | 2/54 | 5/26,336 | 0.000041 | 0.033663278 |
| GO:0052805 | imidazole-containing compound catabolic process | 2/54 | 5/26,336 | 0.000041 | 0.033663278 |
|
| |||||
| GO:0070613 | regulation of protein processing | 7/66 | 118/26,336 | 0.000000019 | 0.000136706 |
| GO:1903317 | regulation of protein maturation | 7/66 | 118/26,336 | 0.000000019 | 0.000136706 |
| GO:0010955 | negative regulation of protein processing | 6/66 | 76/26,336 | 0.000000037 | 0.000136706 |
| GO:1903318 | negative regulation of protein maturation | 6/66 | 76/26,336 | 0.000000037 | 0.000136706 |
| GO:0097340 | inhibition of cysteine-type endopeptidase activity | 5/66 | 55/26,336 | 0.00000027 | 0.000570047 |
| GO:0097341 | zymogen inhibition | 5/66 | 55/26,336 | 0.00000027 | 0.000570047 |
| GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process | 5/66 | 55/26,336 | 0.00000027 | 0.000570047 |
| GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5/66 | 125/26,336 | 0.000016 | 0.025527364 |
| GO:0016485 | protein processing | 7/66 | 322/26,336 | 0.000016 | 0.025527364 |
| GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 5/66 | 128/26,336 | 0.000018 | 0.025527364 |
| GO:0035499 | carnosine biosynthetic process | 2/66 | 3/26,336 | 0.000019 | 0.025527364 |
| GO:0051604 | protein maturation | 7/66 | 349/26,336 | 0.000027 | 0.03325275 |
| GO:0045861 | negative regulation of proteolysis | 6/66 | 245/26,336 | 0.000035 | 0.039789615 |
| GO:0010951 | negative regulation of endopeptidase activity | 5/66 | 154/26,336 | 0.000043 | 0.043633238 |
| GO:0010466 | negative regulation of peptidase activity | 5/66 | 157/26,336 | 0.000047 | 0.043633238 |
| GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 3/66 | 29/26,336 | 0.000052 | 0.043633238 |
| GO:0006548 | histidine catabolic process | 2/66 | 5/26,336 | 0.000062 | 0.043633238 |
| GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate | 2/66 | 5/26,336 | 0.000062 | 0.043633238 |
| GO:0035498 | carnosine metabolic process | 2/66 | 5/26,336 | 0.000062 | 0.043633238 |
| GO:0050812 | regulation of acyl-CoA biosynthetic process | 2/66 | 5/26,336 | 0.000062 | 0.043633238 |
| GO:0052805 | imidazole-containing compound catabolic process | 2/66 | 5/26,336 | 0.000062 | 0.043633238 |
M is the number of all the genes with GO annotation; m is the number of DEGs in M; N is the number of all the genes that are annotated to the certain GO terms; n is the number of DEGs in N.
Figure 4Scatterplot of KEGG pathways enriched in the DEGs for each pairwise comparison [(A) S14 vs S22; (B) S14 vs S30; (C) S22 vs S30]. “Rich factor” represents the ratio of DEG numbers annotated with a pathway term relative to all genes annotated with this pathway term. A higher rich factor indicates greater intensity. The qvalue is the corrected p value (range, 0 to 1), and a lower q value denotes greater intensity. Only the top 30 enriched pathway terms are shown.
Oligonucleotide primers designed for qRT-PCR of twelve candidate DEGs.
| Unigene-ID | Gene Name | Sequence (5’-3’) | Efficiency | Product Size (bp) |
|---|---|---|---|---|
| TRINITY_DN64699_c0_g1 |
| F: GCAAACTTCTTGCCGTGCGGCA | 97.80% | 168 |
| R: CTGCATGCGACACCCAATCAG | ||||
| TRINITY_DN65676_c2_g1 |
| F: ACGGACCAGGCAGTTGTCGT | 102.43% | 192 |
| R: CGCCGGTTGTGTGGCCACCCTGT | ||||
| TRINITY_DN65035_c3_g1 |
| F: GAATCTTCTCGCAAATCCGCG | 98.15% | 177 |
| R: ATTGATTGTTGTGCTTCCC | ||||
| TRINITY_DN53170_c0_g1 |
| F: ACCGCCGAACCAGTATTTGGC | 107.81% | 204 |
| R: CAGGAAACACGGAGCCGATG | ||||
| TRINITY_DN63352_c4_g2 |
| F: AGTTTGACCTCCTGCTGACC | 101.92% | 225 |
| R: TGACATCTTGAAATCCGGGCA | ||||
| TRINITY_DN57342_c5_g1 |
| F: CGCAACCTGCCTAAGTCTCT | 98.75% | 159 |
| R: GGTCCGCTACGTTGTGACCGC | ||||
| TRINITY_DN41276_c0_g1 |
| F: CTTCTAACTGCTCCTTCGGAATTC | 105.38% | 207 |
| R: GAACACACCACGGCACTAAGCC | ||||
| TRINITY_DN63081_c2_g1 |
| F: CAGATAACATCAGTTCTGGACG | 96.75% | 190 |
| R: ACCGGTCAATGTTCCAGTCCTT | ||||
| TRINITY_DN72946_c3_g5 |
| F: ATCCTCTTGGACATCACCGA | 100.37% | 146 |
| R: GGAACAGGACCAGGCAGAAG | ||||
| TRINITY_DN59014_c0_g1 |
| F: GACCGGTGATGAAGAATTG | 99.26% | 188 |
| R: GTTAAAGCCTAGCAGATT | ||||
| TRINITY_DN66154_c0_g2 |
| F: ACACCTCCGACGAAATATTCC | 101.79% | 201 |
| R: CATCAACCGGGACACGATCGCC | ||||
| TRINITY_DN64918_c2_g2 |
| F: CACTTCAATCGCCTGGTTCAAT | 98.59% | 173 |
| R: GACCCCTGGTATTTGTGCCAG |
F: forward primer; R: reverse primer.
Figure 5Genes selected for real-time PCR validation and the fold change in three salinity treatments for both RNA-seq and RT-PCR analysis. IAP, inhibitor of apoptosis protein; BIRC3, baculoviral IAP repeat-containing protein 3; GLUL, glutamine synthetase; GADD45G, growth arrest and DNA damage-inducible protein; CECR5, cat eye syndrome critical region protein 5; CHKB, choline/ethanolamine kinase; TKTL1, transketolase-like protein 1; UCP2, mitochondrial uncoupling protein 2; CYP2G1, cytochrome P450 2G1; CARNS1, carnosine synthase 1; GRP78, glucose-regulated protein; RPL39, ribosomal protein L39. The relative expression values were normalized to β-actin gene expression. Vertical bars represent the mean ± S.D. (n = 3).